Antu Eapan Thomas
Stock Analyst at Geojit Research
(1.02)
# 3,918
Out of 5,058 analysts
44
Total ratings
38.5%
Success rate
-2.5%
Average return
Main Sectors:
Stocks Rated by Antu Eapan Thomas
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| NSE: MANKIND Mankind Pharma Limited | Reiterated: Buy | ₹2,660 | ₹2,294 | +15.96% | 1 | Jun 16, 2026 | |
| NSE: FORTIS Fortis Healthcare Limited | Reiterated: Buy | ₹1,150 | ₹741.25 | +55.14% | 1 | Jun 15, 2026 | |
| NSE: PVRINOX PVR INOX Limited | Reiterated: Buy | ₹1,065 → ₹1,189 | ₹1,402 | -15.17% | 2 | Jun 5, 2026 | |
| NSE: RAINBOW Rainbow Children's Medicare Limited | Initiated Coverage: Buy | ₹1,679 | ₹1,228 | +36.72% | 1 | May 27, 2026 | |
| NSE: SBICARD SBI Cards and Payment Services Limited | Reiterated: Buy | ₹950.00 → ₹698.00 | ₹569.30 | +22.61% | 2 | May 18, 2026 | |
| NSE: LICI Life Insurance Corporation of India | Reiterated: Buy | ₹544.00 → ₹467.00 | ₹394.80 | +18.29% | 3 | Mar 18, 2026 | |
| NSE: NBCC NBCC (India) Limited | Rated: Hold | n/a | $75.65 | - | 1 | Mar 17, 2026 | |
| NSE: GODREJPROP Godrej Properties Limited | Reiterated: Buy | ₹2,096 | ₹1,599 | +31.06% | 1 | Feb 26, 2026 | |
| NSE: AMBER Amber Enterprises India Limited | Initiated Coverage: Buy | ₹9,156 | ₹6,658 | +37.52% | 1 | Feb 23, 2026 | |
| NSE: HCG HealthCare Global Enterprises Limited | Upgraded: Buy | ₹628.00 → ₹724.00 | ₹583.80 | +24.02% | 2 | Feb 19, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | ₹780.00 | ₹679.80 | +14.74% | 1 | Feb 19, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | ₹1,180 | ₹849.00 | +38.99% | 1 | Feb 16, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | ₹568.00 → ₹791.00 | ₹248.50 | +218.31% | 3 | Feb 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | ₹686.00 | ₹522.80 | +31.22% | 1 | Feb 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | ₹4,409 → ₹4,560 | ₹3,652 | +24.86% | 2 | Feb 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | ₹857.00 → ₹828.00 | ₹544.90 | +51.95% | 4 | Jan 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | ₹2,244 → ₹2,080 | ₹1,685 | +23.46% | 2 | Jan 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | ₹312.00 → ₹439.00 | ₹350.20 | +25.36% | 2 | Jan 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | ₹1,076 | ₹955.75 | +12.58% | 1 | Jan 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | ₹1,085 | ₹1,046 | +3.78% | 1 | Nov 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | ₹2,254 | ₹1,669 | +35.08% | 1 | Nov 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | ₹1,790 → ₹1,613 | ₹1,767 | -8.71% | 2 | Nov 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | ₹1,015 | ₹733.65 | +38.35% | 1 | Oct 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | ₹1,820 | ₹1,187 | +53.31% | 1 | Oct 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | ₹1,791 → ₹1,247 | ₹407.05 | n/a | 2 | Oct 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | ₹3,691 | ₹2,420 | n/a | 1 | Jul 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | ₹386.00 | ₹143.46 | n/a | 1 | Jun 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | ₹2,770 | ₹1,054 | n/a | 1 | Apr 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | ₹326.00 | ₹293.35 | n/a | 1 | Dec 10, 2024 |
Mankind Pharma Limited
Jun 16, 2026
Reiterated: Buy
Price Target: ₹2,660
Current: ₹2,294
Upside: +15.96%
Fortis Healthcare Limited
Jun 15, 2026
Reiterated: Buy
Price Target: ₹1,150
Current: ₹741.25
Upside: +55.14%
PVR INOX Limited
Jun 5, 2026
Reiterated: Buy
Price Target: ₹1,065 → ₹1,189
Current: ₹1,402
Upside: -15.17%
Rainbow Children's Medicare Limited
May 27, 2026
Initiated Coverage: Buy
Price Target: ₹1,679
Current: ₹1,228
Upside: +36.72%
SBI Cards and Payment Services Limited
May 18, 2026
Reiterated: Buy
Price Target: ₹950.00 → ₹698.00
Current: ₹569.30
Upside: +22.61%
Life Insurance Corporation of India
Mar 18, 2026
Reiterated: Buy
Price Target: ₹544.00 → ₹467.00
Current: ₹394.80
Upside: +18.29%
NBCC (India) Limited
Mar 17, 2026
Rated: Hold
Price Target: n/a
Current: $75.65
Upside: -
Godrej Properties Limited
Feb 26, 2026
Reiterated: Buy
Price Target: ₹2,096
Current: ₹1,599
Upside: +31.06%
Amber Enterprises India Limited
Feb 23, 2026
Initiated Coverage: Buy
Price Target: ₹9,156
Current: ₹6,658
Upside: +37.52%
HealthCare Global Enterprises Limited
Feb 19, 2026
Upgraded: Buy
Price Target: ₹628.00 → ₹724.00
Current: ₹583.80
Upside: +24.02%
Feb 19, 2026
Reiterated: Buy
Price Target: ₹780.00
Current: ₹679.80
Upside: +14.74%
Feb 16, 2026
Upgraded: Buy
Price Target: ₹1,180
Current: ₹849.00
Upside: +38.99%
Feb 11, 2026
Reiterated: Buy
Price Target: ₹568.00 → ₹791.00
Current: ₹248.50
Upside: +218.31%
Feb 10, 2026
Reiterated: Buy
Price Target: ₹686.00
Current: ₹522.80
Upside: +31.22%
Feb 1, 2026
Reiterated: Buy
Price Target: ₹4,409 → ₹4,560
Current: ₹3,652
Upside: +24.86%
Jan 29, 2026
Reiterated: Buy
Price Target: ₹857.00 → ₹828.00
Current: ₹544.90
Upside: +51.95%
Jan 28, 2026
Reiterated: Buy
Price Target: ₹2,244 → ₹2,080
Current: ₹1,685
Upside: +23.46%
Jan 2, 2026
Upgraded: Buy
Price Target: ₹312.00 → ₹439.00
Current: ₹350.20
Upside: +25.36%
Jan 1, 2026
Downgraded: Hold
Price Target: ₹1,076
Current: ₹955.75
Upside: +12.58%
Nov 11, 2025
Upgraded: Buy
Price Target: ₹1,085
Current: ₹1,046
Upside: +3.78%
Nov 10, 2025
Reiterated: Buy
Price Target: ₹2,254
Current: ₹1,669
Upside: +35.08%
Nov 7, 2025
Reiterated: Buy
Price Target: ₹1,790 → ₹1,613
Current: ₹1,767
Upside: -8.71%
Oct 31, 2025
Reiterated: Buy
Price Target: ₹1,015
Current: ₹733.65
Upside: +38.35%
Oct 31, 2025
Upgraded: Buy
Price Target: ₹1,820
Current: ₹1,187
Upside: +53.31%
Oct 8, 2025
Reiterated: Buy
Price Target: ₹1,791 → ₹1,247
Current: ₹407.05
Upside: n/a
Jul 15, 2025
Reiterated: Buy
Price Target: ₹3,691
Current: ₹2,420
Upside: n/a
Jun 9, 2025
Reiterated: Buy
Price Target: ₹386.00
Current: ₹143.46
Upside: n/a
Apr 2, 2025
Reiterated: Hold
Price Target: ₹2,770
Current: ₹1,054
Upside: n/a
Dec 10, 2024
Reiterated: Hold
Price Target: ₹326.00
Current: ₹293.35
Upside: n/a